Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1997-05-12
1998-08-18
Huff, Sheela
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 13, 514 14, 514 15, 514 16, 514 17, 514 18, 514 19, A61K 3800
Patent
active
057958661
ABSTRACT:
The present invention relates, in general, to methods for reducing cell tumorigenicity. More particularly, the present invention provides a method for reducing cell tumorigenicity comprising transfecting a tumor cell with an ETS1 gene, the tumor cell not endogenously expressing the ETS1 gene. In addition, the present invention provides a method for reducing cell tumorigenicity comprising contacting a tumor cell with a peptide expressed by an ETS1 gene, the tumor cell not endogenously expressing the ETS1 gene. The methods of the present invention are particularly useful for reducing tumorigenicity in epithelial tumor cells.
REFERENCES:
patent: 5629192 (1997-05-01), Suzuki et al.
Bhat Narayan K.
Papas Takis S.
Suzuki Hiroaki
Huff Sheela
The United States of America as represented by the Department of
LandOfFree
ETS1 gene: a human tumor suppressor gene does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with ETS1 gene: a human tumor suppressor gene, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and ETS1 gene: a human tumor suppressor gene will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1114793